US Stock MarketDetailed Quotes

IMTXW Immatics N V C/Wts 01/07/2025 (To Pur Com)

Watchlist
  • 0.990
  • +0.036+3.73%
Close Nov 1 16:00 ET
0.990High0.390Low

About Immatics N V C/Wts 01/07/2025 (To Pur Com) Company

Immatics NV is a clinical stage biopharmaceutical company, which engages in the research and development of T cell receptor-based immunotherapies for the treatment of cancer. Its pipeline includes adoptive cell therapy and TCR Bispecifics. The company was founded on March 10, 2020, and is headquartered in Tuebingen, Germany.

Company Profile

SymbolIMTXW
Company NameImmatics N V C/Wts 01/07/2025 (To Pur Com)
Listing DateJul 2, 2020
Founded2020
CEODr. Harpreet Singh, PhD
MarketNASDAQ
Employees535
Fiscal Year Ends12-31
AddressPaul-Ehrlich-Strasse 19
CityTuebingen
ProvinceBaden Wuerttemberg
CountryGermany
Zip Code72076
Phone49-7071-5397-0
Websitehttp://www.immatics.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Harpreet Singh, PhD
  • Director and Chief Executive Officer
  • 7.50M
  • Arnd Christ
  • Chief Financial Officer
  • --
  • Dr. Toni Weinschenk, PhD
  • Chief Innovation Officer
  • --
  • Dr. Carsten Reinhardt,M.D.,PhD
  • Chief Development Officer
  • --
  • Dr. Cedrik Britten, M.D.
  • Chief Medical Officer
  • --
  • Dr. Steffen Walter, PhD
  • Chief Operations Officer
  • --
  • Dr. Rainer Kramer, PhD
  • Chief Business Officer
  • --
  • Peter Alan Chambre
  • Chairman of the Board
  • 283.00K
  • Edward Sturchio, J.D.
  • General Counsel
  • --
  • Adam Stone
  • Member of the Supervisory Board
  • 246.00K
  • Jordan Silverstein
  • Head of Strategy
  • --
  • Paul Rutherford Carter
  • Member of the Supervisory Board
  • 259.00K
  • Michael G. Atieh
  • Member of the Supervisory Board
  • 263.00K
  • Dr. Eliot Richard Forster, M.B.A.,PhD
  • Member of the Supervisory Board
  • 249.00K
  • Heather L. Mason
  • Member of the Supervisory Board
  • 246.00K
  • Dr. Mathias Hothum, PhD
  • Member of the Supervisory Board
  • 120.00K